Find trials
Search tips

A Study Screening And Therapeutic Biomarkers For CerTra Syndrome

Overview

About this study

The purpose of this study is to characterize lipids in patient-derived samples by tandem mass spectrometry to identify candidate biomarkers of CerTra syndrome and also profile longitudinal changes in these molecules during treatment to evaluate therapeutic response.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Healthy participants without diagnosis of genetic disorders

  • Participants with CerTra syndrome

 

Exclusion Criteria: 

  • None

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 04/06/2026. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Seul Kee Byeon, Ph.D.

Contact us for the latest status

Contact information:

Susan Holtegaard

5072848359

holtegaard.susan@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20605649

Mayo Clinic Footer